ArticleNeuro-oncology advances
An interpretable machine learning model for identifying granulation patterns in somatotroph tumors: A multi-center radiomics study.
Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To develop non-invasive, interpretable machine learning (ML) models using radiomic and clinical -features to distinguish sparsely granulated (SGST) and densely granulated (DGST) somatotroph tumors by leveraging preoperative multiparametric magnetic resonance imaging (MRI) and clinical data. Methods: We retrospectively analyzed 201 patients (107 DGST, 94 SGST) with surgically treated somatotroph tumors across four institutions (156 in the training cohort, 45 in the external validation cohort). From preoperative contrast-enhanced T1 and T2-weighted MRI scans, 3004 radiomic features were extracted using Pyradiomics. Feature selection involved least absolute shrinkage and selection operator (LASSO), and the Boruta algorithm. Six ML-algorithms were evaluated, with the support vector machine (SVM) model selected for tumor subtype classification. Shapley Additive Explanations (SHAP) enhanced model interpretability by ranking feature importance. Results: The SVM model, integrating eight radiomic features and five clinical factors, achieved areas under the curve (AUCs) of 0.828 in the internal training cohort and 0.820 in the external validation cohort. SHAP analysis identified key radiomic and clinical predictors, enhancing the model's transparency and clinical applicability. Conclusion: This multi-center study validates an interpretable, radiomics-based SVM model with high accuracy and generalizability for preoperative classification of somatotroph tumor granulation patterns. By offering a non-invasive tool to predict tumor subtypes, this approach enhances personalized treatment planning and holds translational potential for improving acromegaly management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.